2. Professors
  3. TERLIZZI Michela
  4. Curriculum

Curriculum

Michela TERLIZZI Curriculum

Education

  • PhD viva in Drug Discovery and Development-Cycle XXIX, Department of Pharmacy, University of Salerno (Italy). Thesis title: ‘Role of the Inflammasome in Lung Cancer’ (20.03.17);
  • ‘Understanding Biomarker Science: From Molecules to Images’ Joseph B. Martin Conference Center, Longwood Medical Area, Boston, Massachusetts (04.2016);
  • ‘EPI293: Analysis of Genetic Association Study’ Harvard T.H. Chan School of Public Health, Boston, Massachusetts (01.2016);
  • PhD student in Drug Discovery and Development-Cycle XXIX, Department of Pharmacy, University of Salerno (Italy);
  • Master’s Degree in RadioPharmacy, University of Bari (Italy) (01.2013-12.2013);
  • Bachelor’s Degree in Pharmacy (110/110 cum laude), Department of Pharmacy, University of Salerno (Italy). Thesis title: ‘Toll-like receptor-3: anti-tumor activity in a mouse model of lung cancer’ (27.07.2012).

Research Experience

  • Research fellow in Physiology-Type B. Department of Pharmacy, University of Salerno (Italy) (01.02.2022-31.01.2025);
  • Fellowship in ‘Bioinformatics analysis for the identification of biomarkers related to pulmonary pathophysiology’-Department of Epidemiology, Harvard T.H. Chan School of Public Health (Boston, MA) (01.10.2021-31.03.2022);
  • Research fellow in Physiology-Type A-AIM ‘Attraction and International Mobility’, Department of Pharmacy, University of Salerno (Italy) (01.08.2019-31.01.2022);
  • Research fellow, Department of Pharmacy, University of Salerno (Italy). Project title: ‘Inflammation-driven lung cancer: the role of the inflammasome’ (02.2018-07.2019);
  • Research fellow (SIF BMS fellowship), Department of Pharmacy, University of Salerno (Italy). Project title: ‘Alteration of mitochondrial DNA potential involvement in lung cancer establishment’ (02.2017-01.2018);
  • Academic visitor in ‘High-throughput Molecular and Genetics Epidemiologic Studies’ as Visiting PhD Student-Department of Epidemiology, Harvard T.H. Chan School of Public Health (Boston, MA) (11.2015-04.2016);
  • Lab training as PhD student in ‘Drug Discovery and Development-Cycle XXIX’, Department of Pharmacy, University of Salerno (Italy) (01.2014-12.2016);
  • Research fellow, Department of Pharmacy, University of Salerno (Italy). Project title: ‘Study of Dendritic Cells in murine lung cancer models’ (06.2013-12.2013);
  • Job Placement, Department of Pharmacy, University of Salerno, (Italy) (09.2012-05.2013);
  • Lab training, Department of Pharmacy, University of Salerno (Italy) (2011-2012).

Prizes

  • Travel Award 2022, International Union of Physiological Sciences-IUPS, 39th Congress of the International Union of Physiological Sciences (07-11 May 2022);
  • Early Career Award 2022, American Physiological Society-APS, Experimental Biology conference 2022 (02-05 April 2022);
  • 2021 Steven M. Horvath Research Recognition Award, American Physiological Society-APS Cell and Molecular Physiology Section, Experimental Biology conference 2021 (30 April 2021);
  • SIF-Farmindustria 2019 Award (25.10.2019);
  • Best Poster Presentation ‘Tumor-associated macrophages promote inflammasome-dependent lung tumor progression in mice’-European Respiratory Society (ERS) 15th Lung Science Conference-Mechanistic overlap between chronic lung injury and cancer 2017 (23-26 March 2017 Estoril-Portugal);
  • Travel Grant-European Respiratory Society (ERS) 15th Lung Science Conference-Mechanistic overlap between chronic lung injury and cancer 2017 (23-26 March 2017 Estoril-Portugal);
  • Special Award from the UK Trade&Investment for Future Ideas regarding the project: ‘Specific reagents for the modulation of plasmacytoid Dendritic Cell activity: new targets for diagnosis, prognosis and therapy’ (01.2013).
  • Special Award from the UK Council for the project: ‘Specific reagents for the modulation of plasmacytoid Dendritic Cells activity: new targets for diagnosis, prognosis and therapy’ (10.2012);
  • Start Cup Campania Prize 2012 for the project: ‘Specific reagents for the modulation of plasmacytoid Dendritic Cells activity: new targets for diagnosis, prognosis and therapy’ (10.2012).

Technology Transfer

  • Patent request: RM2014A000080, Title: BIOMARCATORI DEL TUMORE POLMONARE, E RELATIVI METODI DIAGNOSTICI E KIT (22.11.2016);
  • Patent request: PCT/IB2015/051262, Title: LUNG CANCER’S BIOMARKER AND METHODS AND DIAGNOSTIC KIT (27.08.2015);
  • Co-founder and partner of a university spin-off, ImmunePharma srl, assistant to production; isolation of biological fluids and cells from tissues, screening and research phase and development, as can be seen from the link http://www.immunepharma.it/board-of-directors/ (04.02.2015 to 30.11.2020).